Neurological & Neurocognitive Complications & HIV/AIDS: News/Research
- NIH Awards Einstein College of Medicine $3 Million Grant to Create Center for HIV-Related Brain Disease (June 15, 2009)
From Yeshiva University
- Language Impairment May Be More Common Than Previously Thought in Perinatally HIV-Infected Children, Study Suggests (February 11, 2009)
One-third of 178 perinatally HIV-infected children scored low on language assessments in the 12-site prospective cohort study, explained Mabel Rice, Ph.D. There appeared to be a relationship between risk of secondary language impairment and any of three factors at study enrollment: CDC Class C; viral load >400 copies/mL; and CD4+ percentage <25%.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Up to Half of HIV-Infected Patients on Effective HAART Still Ultimately Develop Neurocognitive Impairment, Study Finds (February 11, 2009)
Igor Grant, M.D., presents new data from the CHARTER study indicating that, although the prevalence of dementia is significantly down in the modern treatment era, 40 percent to 50 percent of HIV-infected patients on effective HAART will still eventually develop some form of neurological impairment -- and in most cases, the impairment will impact their day-to-day lives.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Illnesses Associated With Aging May Strike HIVers Earlier, Study Suggests (January 26, 2009)
From National AIDS Treatment Advocacy Project
- Signs Emerge That Isentress May Temporarily Worsen Existing Depression (September 2, 2008)
From aidsmap.com
- HIV-Positive On HAART Less Likely to Experience Brain Damage, Study Says (October 10, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- HIVers on Meds May Be Less Likely to Develop Brain Damage, Study Says (October 9, 2007)
In Neurology
- HIV Treatment May Improve Brain Function in People With Advanced HIV, Study Finds (June 5, 2007)
From aidsmap.com
- HIV JournalView: Efavirenz Has No Significant, Lasting Impact on Neuropsychological Performance (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
- Higher Efavirenz Plasma Levels May Increase Neuropsychiatric Complication Risk (December 15, 2005)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- AIDS Reduces Brain Tissue in Certain Regions Despite HAART, Study Says (October 12, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Meth Use, HIV Infection Linked to Changes in Brain Structure That Can Impair Cognitive Functions, Study Says (August 15, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Minocycline May Have Protective Effect Against HIV-Related Neurological Complications, Research Suggests (July/August 2005)
[Archived Article]
Intriguing findings reported in SIV-infected monkeys receiving this inexpensive antibiotic.
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Neuropsychiatric Symptoms From Efavirenz Not Always Time-Limited (May/June 2005)
[Archived Article]
More than half of 120 Spanish patients report persistent, though usually mild, symptoms after nearly two years.
From The Body PRO
- The Genomics of Efavirenz Toxicity (January 2005)
[Archived Article]
Part of HIV JournalView's Top 10 Research Reports of 2004.
In The 12th International AIDS Conference, from The Body PRO
- Previous Alcohol Abuse May Reduce HIV Patients' Cognitive Function (March 18, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Neurologic Side Effects of Efavirenz Not Affected by the Drug's Blood Levels (March/April 2004)
[Archived Article]
In Positively Aware, from Test Positive Aware Network
- HIVers Over 50 at Increased Risk of Cognitive Impairment, Even With HAART (February 19, 2004)
[Archived Article]
From aidsmap.com
- Dementia: Brain Damage Found in HIV Patients on Antiretroviral Therapy (January 16, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Acquired Immunodeficiency Syndrome and the Risk of Stroke (December 18, 2003)
[Archived Article]
Abstract of a U.S. study finding a greatly increased likelihood of stroke among AIDS patients.
In Stroke
- Prediction of Incident Neurocognitive Impairment by Plasma HIV RNA and CD4 Levels Early After HIV Seroconversion (November 2003)
[Archived Article]
Abstract of a study in the Archives of Neurology.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- ACTG 5097s: Efavirenz-Related CNS Events in the 5095 Study (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Memory Problems Increase Patients' Wish to Die (June 13, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Efavirenz More Durable Than Nevirapine, But CNS Toxicity Underestimated (April 29, 2003)
[Archived Article]
British researchers find that efavirenz works better over the long term, but that its psychiatric side effects persist a lot longer than previously thought.
From aidsmap.com
- Psychiatric and Neuropsychiatric Manifestations of HIV Infection (April 4, 2003)
[Archived Article]
A slide presentation by Ewald Horwath, M.D.
- Crossing the Blood-Brain Barrier (Summer 2002)
[Archived Article]
Vitamin C may help many medications more effectively reach the brain.
In Women Alive Newsletter, from Women Alive
- HIV Infection May Trigger Neurologic Disorder (January/February 2002)
[Archived Article]
In Body Positive, from Body Positive
- Anemia Symposium Discusses Relationship With HIV, Cancer, Hepatitis C; Discusses Erythropoietin Use (December 16, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
- Cerebrospinal Fluid HIV-1 RNA Levels Peak During Primary HIV-1 Infection (February 5, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Gender and Neurological Functioning in HIV Infection (January 31, 2000)
[Archived Article]
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
|
|
Advertisement
|
E-Mail
Glossary
Share
